title: The impurities of capreomycin make a difference in the safety and pharmacokinetic profiles.
authors.forename: Sung Hak
authors.initials: SH
authors.lastname: Lee
authors.forename: Jaekyu
authors.initials: J
authors.lastname: Shin
authors.forename: Jae Mook
authors.initials: JM
authors.lastname: Choi
authors.forename: Eun Young
authors.initials: EY
authors.lastname: Lee
authors.forename: Dal Hyun
authors.initials: DH
authors.lastname: Kim
authors.forename: Jung-Woo
authors.initials: JW
authors.lastname: Suh
authors.forename: Jun Hwan
authors.initials: JH
authors.lastname: Chang
mesh_terms: D000818:Animals; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity*; D002207:Capreomycin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity*; D004340:Drug Contamination; D005260:Female; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000904:Antibiotics, Antitubercular; D002207:Capreomycin